Omer Jamy

30PUBLICATIONS
147CO-AUTHORS
Gene and molecular therapyHaematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 06, 2026
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study.

|Jul 19, 2026
An Unusual Presentation of Philadelphia Chromosome Positive B-Cell Acute Lymphoblastic Leukemia With Isolated Osteolytic Lesions at Diagnosis: A Case Report.

|Jun 12, 2026
Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Mar 27, 2026
Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice.

Mohammad Shahzaib Qadir, Omer Jamy

|Feb 11, 2026
American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults.

Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung

Pageof 5

Frequent Collaborators

5 joint publications

Bhagirathbhai Dholaria

4 joint publications

Luciano J Costa

4 joint publications

Talha Badar

4 joint publications

Sravanti Rangaraju